Quad-Cities Investment Group »

Crispr Therapeutics shares owned by Quad-Cities Investment Group

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Quad-Cities Investment Group from 13F filings

Historical chart of Quad-Cities Investment Group investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Quad-Cities Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Quad-Cities Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $227k 4.2k 54.54

More positions owned by Quad-Cities Investment Group

Apple (AAPL)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr Core S&p Mcp Etf (IJH)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Scp Etf (IJR)
Wells Fargo & Company (WFC)

View all positions for Quad-Cities Investment Group

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
Geode Capital Management
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Susquehanna International
Two Sigma Investments
EcoR1 Capital
Citadel Advisors

View all funds holding Crispr Therapeutics